International Journal of Infertility & Fetal Medicine

Register      Login

VOLUME 5 , ISSUE 3 ( September-December, 2014 ) > List of Articles


Effect of Intrauterine Instillation of Granulocyte Colony-stimulating Factor on Endometrial Thickness and Clinical Pregnancy Rate in Women undergoing in vitro Fertilization Cycles: An Observational Cohort Study

Jatin Shah, Aparna Gangadharan

Citation Information : Shah J, Gangadharan A. Effect of Intrauterine Instillation of Granulocyte Colony-stimulating Factor on Endometrial Thickness and Clinical Pregnancy Rate in Women undergoing in vitro Fertilization Cycles: An Observational Cohort Study. Int J Infertil Fetal Med 2014; 5 (3):100-106.

DOI: 10.5005/jp-journals-10016-1090

License: CC BY-NC 4.0

Published Online: 01-04-2017

Copyright Statement:  Copyright © 2014; The Author(s).



In spite of significant advances in the field of reproductive medicine, repeated implantation failure (RIF) is a challenging and extremely disappointing problem. The success of in vitro fertilization and embryo transfer (IVF-ET) cycles depends mainly on uterine receptivity and embryo quality. Successful evaluation of endometrial receptivity conducive to embryo implantation continues to be a challenge in assisted reproductive technology (ART). Several researcher groups have reported the successful use of granulocyte-colony stimulating factor (G-CSF) during IVF cycles in terms of achieving higher clinical pregnancy rates on account of increased endometrial thickness. Women who fail to achieve adequate endometrial thickness despite conventional treatment with high dose estrogen or those with a history of repeated implantation failures in spite of normal endometrial thickness often do not achieve pregnancy and resort to gestational surrogacy. A new therapeutic approach to achieve successful pregnancy in such patients would be very desirable.

Study objectives

To assess the efficacy of a single dose of intrauterine G-CSF on endometrial thickness, implantation and clinical pregnancy rates in women who either had a thin endometrium after estrogen priming (< 8 mm) or a history of repeated implantation failures at IVF, undergoing embryo transfer after 10 days of priming with oral estradiol and vaginal slidenafil.

Materials and methods

Two hundred and thirty-one women (between 24 and 46 years of age) undergoing IVF-ET were recruited for the study. All cases were prospectively studied at the Mumbai Fertility Clinic and IVF Center (a subdivision of Kamala Polyclinic and Nursing Home) over a period of 6 months from January to June 2014, after their written informed consent. Subgroup I consisted of 117 patients who had a persistently thin endometrium (< 8 mm) in spite of high dose oral estradiol valerate and vaginal sildenafil priming. Subgroup II consisted of 114 patients who had a history of repeated (two or more) implantation failures (RIF) at IVF-ET cycles despite adequate endometrium (≥8 mm). All were infused with a single dose of G-CSF (300 mcg) in the uterine cavity after 10 days of priming with oral estradiol valerate and vaginal sildenafil citrate. Endometrial thickness was reassessed 4 days after G-CSF instillation. This was followed by administration of intramuscular progesterone in oil (100 mg) daily with embryo transfer on day 5 of progesterone for all patients. All embryo transfers for patients undergoing oocyte donation or embryo donation were done at the 4-cell stage on day 2. All Frozen embryo transfers (FET) of vitrified embryos were at 8 cell stage. Estimation of serum beta hCG was at 14 days post-embryo transfer for all patients. Successful implantation and net clinical pregnancy rate was confirmed based on appearance of gestational sac on sonogram after 10 days and observation of fetal cardiac activity after 20 days of positive β-hCG results.


Out of total 231 patients recruited in the study, 95% patients from subgroup I (n = 111) and 94% patients from subgroup II (n = 107) showed mean increase in endometrial thickness by at least 2.5 mm within 4 days of G-CSF single dose instillation. A total of 218 patients from both subgroups underwent S. β-hCG estimation 14 days post IVF-ET. Out of 103 β-hCG positive patients, 83 showed net clinical pregnancy (fetal cardiac activity present) giving a net pregnancy rate of 38.07% for the whole study group with 37% in the subgroup with thin endometrium (< 8 mm) and 39.25% in the subgroup with adequate (≥8 mm) endometrium with history of two or more failed implantation at previous IVF-ET cycles. There were no adverse events for the whole study population.


There can be a strong possibility with a single dose of 300 mcg intrauterine infusion of G-CSF to achieve significant increase in the endometrial thickness with higher successful pregnancy rate among infertile women under- going IVF-ET cycles with a history of a persistently thin endometrium or repeated implantation failures (rather difficult to treat patients). G-CSF could be a valuable tool to consider before advising the option of surrogacy. In the absence of a control group, our conclusions warrant conduct of further studies.

How to cite this article

Shah J, Gangadharan A, Shah V. Effect of Intrauterine Instillation of Granulocyte Colony-stimulating Factor on Endometrial Thickness and Clinical Pregnancy Rate in Women undergoing in vitro Fertilization Cycles: An Observational Cohort Study. Int J Infertil Fetal Med 2014;5(3):100-106.

PDF Share
  1. Follicular and luteal phase endometrial thickness and echogenic pattern and pregnancy outcome in oocyte donation cycles. J Assist Reprod Genet 2009;26:243-249.
  2. It's time to pay attention to the endometrium. Fertil Steril 2011;96:519-521.
  3. Predictive value of endometrial thickness pattern and sub-endometrial blood flows on the day of hCG by 2D Doppler in in vitro fertilization cycles: a prospective clinical study from a tertiary care unit. J Hum Reprod Sci 2011;4:29-33.
  4. Defective endometrial receptivity. Fertile Steril 2012; 97:1028-1032.
  5. Endometrial receptivity in an in vitro fertilization program as assessed by spiral artery blood flow, endometrial thickness, endometrial volume, and uterine artery blood flow. Fertil Steril 2001;75:361-366.
  6. The relationship between endometrial thickness and outcome of medicated frozen embryo replacement cycles. Fertil Steril 2008;89:832-839.
  7. The impact of endometrial thickness and texture on intracytoplasmic sperm injection outcome. J Reprod Med 2009;54:303-311.
  8. Endometrial thickness and serum oestradiol concentrations as predictors of outcome in oocyte donation. Hum Reprod 1997;12:2271-2276.
  9. Endometrial thickness: a predictor of implantation in ovum recipients? Hum Reprod 1994;9:363-365.
  10. The effect of endometrial thickness on in vitro fertilization (IVF)-embryo transfer/intracytoplasmic sperminjection (ICSI) outcome. Afr J Reprod Health 2009;13:113-121.
  11. Decidua in human implantation. Human Reproduction 1995;10(2):14-21.
  12. Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization. Fertility and Sterility 2003;79(6):1317-1322.
  13. Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance. J Immunology 2005;175(11):7085-7091.
  14. Detection of granulocyte colony-stimulating factor and its receptor in human follicular luteinized granulose cells. Fertility and Sterility, 2004;81(supp 1):786-791.
  15. Identification and charac- terization of receptors for granulocyte colony-stimulating factor on human placenta and trophoblastic cells. Proceedings of the National Academy of Sciences of the United States of America 1989;86(23):9323-9326.
  16. Use of granulocyte colonystimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Human Reproduction 2009;24(11):2703-2708.
  17. Exogenous granulocyte-macrophage colony-stimulating factor promotes follicular development in the newborn rat in vivo. Human Reproduction 2005;20(10):2749-2756.
  18. Successful treatment of unresponsive thin endometrium. Fertility and Sterility 2011;95(6): 2123.e13-2123.e17.
  19. A pilot cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive thin endometrium resistant to standard therapies. Human Reproduction 2013;28(1):172-177.
  20. Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplantation 2000;25(11): 1197-1201.
  21. The correlation between endometrial thickness and outcome of in vitro fertilization and embryo transfer (IVFET) outcome. Reproductive Biology and Endocrinology 2008;6:article 37.
  22. Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study. Fertility and Sterility 1997;68(5):927-930.
  23. Endometrial thickness is a valid monitoring parameter in cycles of ovulation induction with menotropins alone. Fertility and Sterility 1996;65(2):262-266.
  24. Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone. Human Reproduction 1998;13(12):3421-3424.
  25. Thin unresponsive endometrium—a possible complication of surgical curettage compromising ART outcome. J Assisted Reproduc Genetics 2008;25(8):421-425.
  26. Combined treatment by pentoxifyl line and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation programme. Human Reproduction 2002;17(5):1249-1253.
  27. Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertility and Sterility 2002;78(5):1073-1076.
  28. Prospective evaluation of the ultrasound appearance of the endometrium in a cohort of 1,186 infertile women. Fertility and Sterility 2000;73(1): 106-113.
  29. Endometrial ultrasonography as a predictor of pregnancy in an in vitro fertilization programme. Human Reproduction 1993;8(8):1312-1315.
  30. Granulocyte colony-stimulating factor administration: adverse events. Transfusion Medicine Reviews 2008;22(4): 280-290.
  31. Establishment of a successful pregnancy following in vitro fertilization with an endometrial thickness of no more than 4 mm. Human Reproduction 1998;13(6): 1550-1552.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.